Literature DB >> 30315966

Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections.

Xufeng Tao1, Lianhong Yin1, Lina Xu1, Jinyong Peng2.   

Abstract

Currently, the numbers of patients with cancer, fibrosis, diabetes, chronic kidney disease, stroke and osteoporosis are increasing fast and fast. It's critical necessary to discovery lead compounds for new drug development. Dioscin, one active compound in some medicinal plants, has anti-inflammation, immunoregulation, hypolipidemic, anti-viral, anti-fungal and anti-allergic effects. In recent years, dioscin has reached more and more attention with its potent effects to treat liver, kidney, brain, stomach and intestine damages, and metabolic diseases including diabetes, osteoporosis, obesity, hyperuricemia as well as its anti-cancer activities through adjusting multiple targets and multiple signals. Therefore, dioscin is a promising multi-target candidate to treat various diseases. This review paper summarized the progress on pharmacological activities and mechanisms of dioscin, which may provide useful data for development and exploration of this natural product in the further.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Diabetes; Dioscin; Metabolic disorder; Obesity; Osteoporosis

Mesh:

Substances:

Year:  2018        PMID: 30315966     DOI: 10.1016/j.phrs.2018.09.022

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  23 in total

Review 1.  Herbal compounds in the treatment of pulmonary silicosis.

Authors:  J Adamcakova; D Mokra
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

Review 2.  The role of PI3K/AKT signaling pathway in gallbladder carcinoma.

Authors:  Zeyu Wu; Xiao Yu; Shuijun Zhang; Yuting He; Wenzhi Guo
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

3.  Synthesis and Antitumor Activity of Diosgenin Hydroxamic Acid and Quaternary Phosphonium Salt Derivatives.

Authors:  Lin Wang; Maoling Yao; Yuegao Hu; Congdi Chen; Liming Jin; Xiaodong Ma; Hongjun Yang
Journal:  ACS Med Chem Lett       Date:  2022-04-19       Impact factor: 4.632

4.  Hotspot Analysis of Traditional Drugs in Diabetes Treatment Literature.

Authors:  Hui Shen; Wei-Kai Zhu; Zhi Lu; Hai-Cheng Zhou
Journal:  Chin J Integr Med       Date:  2020-09-30       Impact factor: 1.978

5.  Dioscin elevates lncRNA MANTIS in therapeutic angiogenesis for heart diseases.

Authors:  Chuiyu Kong; Dayin Lyu; Chang He; Rui Li; Qiulun Lu
Journal:  Aging Cell       Date:  2021-06-03       Impact factor: 9.304

6.  Dioscin Inhibits the Invasion and Migration of Hepatocellular Carcinoma HepG2 Cells by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.

Authors:  Bonan Chen; Shikun Zhou; Yujuan Zhan; Junzi Ke; Kun Wang; Qiqi Liang; Yu Hou; Pingping Zhu; Weizhen Ao; Xianli Wei; Jianyong Xiao
Journal:  Molecules       Date:  2019-06-14       Impact factor: 4.411

7.  Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-κb Signal.

Authors:  Shasha Song; Liang Chu; Huifang Liang; Jin Chen; Junnan Liang; Zhao Huang; Bixiang Zhang; Xiaoping Chen
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

8.  RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply.

Authors:  Liang Kong; Fu-Yi Cai; Xue-Min Yao; Ming Jing; Min Fu; Jing-Jing Liu; Si-Yu He; Lu Zhang; Xin-Ze Liu; Rui-Jun Ju; Xue-Tao Li
Journal:  Cancer Sci       Date:  2020-01-18       Impact factor: 6.716

9.  Dioscin attenuates oxLDL uptake and the inflammatory reaction of dendritic cells under high glucose conditions by blocking p38 MAPK.

Authors:  Ying Li; Yong Li; Te Yang; Ming Wang
Journal:  Mol Med Rep       Date:  2019-11-06       Impact factor: 2.952

10.  Induction of G2/M Phase Arrest by Diosgenin via Activation of Chk1 Kinase and Cdc25C Regulatory Pathways to Promote Apoptosis in Human Breast Cancer Cells.

Authors:  Wen-Ling Liao; Jing-Yi Lin; Jia-Ching Shieh; Hsiao-Fong Yeh; Yi-Hsien Hsieh; Yu-Chun Cheng; Huei-Jane Lee; Chen-Yang Shen; Chun-Wen Cheng
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.